Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

The induction of resistance mechanisms represents an important problem for the targeted therapy of patients with non-small-cell lung cancer (NSCLC). The best-known resistance mechanism induced during treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is EGFR T79...

Descripción completa

Detalles Bibliográficos
Autor principal: Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964555/
https://www.ncbi.nlm.nih.gov/pubmed/27455248
http://dx.doi.org/10.3390/ijms17071186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964555/
https://www.ncbi.nlm.nih.gov/pubmed/27455248
http://dx.doi.org/10.3390/ijms17071186

Ejemplares similares